Search Results 1921-1930 of 13396 for monoclonal antibody

1. Waldenstrom macroglobulinemia - Symptoms and causes - Mayo Clinic

   Learn about this rare type of white blood cell cancer. Treatments include chemotherapy, targeted therapy, immunotherapy and bone marrow transplant.

2. Granulomatosis With Polyangiitis Clinical Trials - Mayo Clinic Research

   ... antibody (ANCA)-associated vasculitis (AAV). PR3-AAV Resilient Remission or PRRR Rochester, MN. The purpose of this study is to determine the proportion of ...

3. Bone Biopsy Clinical Trials - Mayo Clinic Research

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

4. A Study Of ANV419 Alone Or In Combination With Approved Treatment In Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

5. Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) - Mayo Clinic

   Known positive for Hepatitis B surfaces antigen, or Hepatitis C antibody, or who have been tested positive for HIV; Patients with any concurrent malignancy ...

6. Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; Serum immunoglobulin free light chain ≥ 10 mg ...

7. A Study Of X4P-001 In Patients With Advanced Renal Cell Carcinoma - Mayo Clinic

   An indeterminate or positive test for antibody to human immunodeficiency virus (HIV-1 or -2) ... Other chemotherapy (e.g., mitomycin-C, nitrosourea) or ...

8. Proton SFRT V. SBRT For Borderline Unresectable/oligometastatic/recurrent Oral Cavity Cancer - Mayo Clinic

   ... antibodies). Patients with a past or resolved HBV infection (defined as presence of hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible.

9. Targeted Therapy Directed By Genetic Testing In Treating Pediatric Patients With Relapsed Or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, Or Histiocytic Disorder - Mayo Clinic

   Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to grade ≤ 1; ...

10. Clinical trials - Oncology (Medical)

    * Whether the body makes antibodies against the study drug(s) (which ... antibody) * Olaparib (a type of PARP inhibitor). Pagination Clinical studies.